NCT06399536 Individualized ANH for Non-cardiac Surgery
| NCT ID | NCT06399536 |
| Status | Recruiting |
| Phase | — |
| Sponsor | West China Hospital |
| Condition | Transfusion Related Complication |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2024-06-01 |
| Primary Completion | 2026-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2024-06-01 with a primary completion date of 2026-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this trial, we proposed an individualized acute normovolemic hemodilution (ANH), and conduct a randomized controlled trial to testify the effect of individualized ANH on red cells requirement for non-cardiac surgeries with anticipating major blood loss in adults.
Eligibility Criteria
Inclusion Criteria: * Patients undergoing elective non-cardiac surgery with an anticipated red blood cells transfusion \>8 units (or 1600ml) * Aged 18\~75 years * Preoperative Hb level \> 120g/L for men and \> 110g/L for women. Exclusion Criteria: * Refusal of blood transfusion * Cardiopulmonary insufficiency * Cerebrovascular disease * Renal impairment * Hemoglobinopathies or blood system diseases * Other situations not suitable for inclusion in clinical trial.
Contact & Investigator
Ren Liao
PRINCIPAL INVESTIGATOR
West China Hospital
Frequently Asked Questions
Who can join the NCT06399536 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Transfusion Related Complication. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06399536 currently recruiting?
Yes, NCT06399536 is actively recruiting participants. Contact the research team at liaoren7733@163.com for enrollment information.
Where is the NCT06399536 trial being conducted?
This trial is being conducted at Chengdu, China.
Who is sponsoring the NCT06399536 clinical trial?
NCT06399536 is sponsored by West China Hospital. The principal investigator is Ren Liao at West China Hospital. The trial plans to enroll 40 participants.